Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Postprandial dysfunction in fatty liver disease.
Grandt J, Jensen AH, Werge MP, Rashu EB, Møller A, Junker AE, Hobolth L, Mortensen C, Johansen CD, Vyberg M, Serizawa RR, Møller S, Gluud LL, Wewer Albrechtsen NJ. Grandt J, et al. Among authors: gluud ll. Physiol Rep. 2023 Apr;11(8):e15653. doi: 10.14814/phy2.15653. Physiol Rep. 2023. PMID: 37078380 Free PMC article. Clinical Trial.
Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy.
Kjeldsen SAS, Gluud LL, Werge MP, Pedersen JS, Bendtsen F, Alexiadou K, Tan T, Torekov SS, Iepsen EW, Jensen NJ, Richter MM, Goetze JP, Rungby J, Hartmann B, Holst JJ, Holst B, Holt J, Gustafsson F, Madsbad S, Svane MS, Bojsen-Møller KN, Wewer Albrechtsen NJ. Kjeldsen SAS, et al. Among authors: gluud ll. iScience. 2023 Oct 12;26(11):108190. doi: 10.1016/j.isci.2023.108190. eCollection 2023 Nov 17. iScience. 2023. PMID: 37953952 Free PMC article.
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis.
Horn P, Norlin J, Almholt K, Viuff BM, Galsgaard ED, Hald A, Zosel F, Demuth H, Poulsen S, Norby PL, Rasch MG, Vyberg M, Fleckner J, Werge MP, Gluud LL, Rink MR, Shepherd E, Northall E, Lalor PF, Weston CJ, Fog-Tonnesen M, Newsome PN. Horn P, et al. Among authors: gluud ll. Elife. 2024 Oct 3;13:RP95185. doi: 10.7554/eLife.95185. Elife. 2024. PMID: 39361025 Free PMC article.
Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.
Winther-Sørensen M, Garcia SL, Bartholdy A, Ottenheijm ME, Banasik K, Brunak S, Sørensen CM, Gluud LL, Knop FK, Holst JJ, Rosenkilde MM, Jensen MK, Wewer Albrechtsen NJ. Winther-Sørensen M, et al. Among authors: gluud ll. Diabetologia. 2024 Aug;67(8):1602-1615. doi: 10.1007/s00125-024-06160-1. Epub 2024 May 6. Diabetologia. 2024. PMID: 38705923 Free PMC article.
Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis.
Grøndahl MFG, Lange AH, Suppli MP, Bagger JI, Thing M, Gluud LL, Kofod DH, Hornum M, van Hall G, Trammell SAJ, Grevengoed TJ, Hartmann B, Holst JJ, Vilsbøll T, Christensen MB, Lund AB, Knop FK. Grøndahl MFG, et al. Among authors: gluud ll. Diabetes. 2024 Oct 1;73(10):1641-1647. doi: 10.2337/db24-0305. Diabetes. 2024. PMID: 39052774 Free PMC article.
227 results